{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T22:21:16Z","timestamp":1783635676775,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T00:00:00Z","timestamp":1687910400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004196","name":"Odense University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006356","name":"University of Southern Denmark","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006356","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005614","name":"Biogen Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008361","name":"Scleroseforeningen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008361","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.jneuroim.2023.578145","type":"journal-article","created":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T00:46:31Z","timestamp":1687826791000},"page":"578145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Whole blood miRNAs in relapsing MS patients treated with dimethyl fumarate in the phase 4 TREMEND trial"],"prefix":"10.1016","volume":"381","author":[{"given":"Maria L.","family":"Elkjaer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rikke M.","family":"Lohse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Burton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason P.","family":"Mendoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mads","family":"Thomassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Sejbaek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsolt","family":"Illes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2023.578145_bb0005","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1212\/WNL.0b013e3182050388","article-title":"Treatment effects of immunomodulatory therapies at different stages of multiple sclerosis in short-term trials","volume":"76","author":"Bates","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2023.578145_bb0010","doi-asserted-by":"crossref","first-page":"5643","DOI":"10.1038\/onc.2008.171","article-title":"Expression of microRNA-146 suppresses NF-\u03baB activity with reduction of metastatic potential in breast cancer cells","volume":"27","author":"Bhaumik","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.jneuroim.2023.578145_bb0015","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.bbrc.2018.11.060","article-title":"MiR-216a-5p protects 16HBE cells from H 2 O 2 -induced oxidative stress through targeting HMGB1\/NF-kB pathway","volume":"508","author":"Chaoyang","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jneuroim.2023.578145_bb0020","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1101\/gr.082701.108","article-title":"Most mammalian mRNAs are conserved targets of microRNAs","volume":"19","author":"Friedman","year":"2009","journal-title":"Genome Res."},{"key":"10.1016\/j.jneuroim.2023.578145_bb0025","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1177\/1352458515578771","article-title":"miRNA in multiple sclerosis: search for novel biomarkers","volume":"21","author":"Gandhi","year":"2015","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2023.578145_bb0030","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.cca.2021.01.020","article-title":"MicroRNA in multiple sclerosis","volume":"516","author":"Gao","year":"2021","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jneuroim.2023.578145_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103126","article-title":"Potential prognostic value of circulating inflamma-miR-146a-5p and miR-125a-5p in relapsing-remitting multiple sclerosis","volume":"54","author":"Giuliani","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.jneuroim.2023.578145_bb0040","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa1114287","article-title":"Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis","volume":"367","author":"Gold","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2023.578145_bb0045","first-page":"1","article-title":"Erythrocyte microRNA sequencing reveals differential expression in relapsing-remitting multiple sclerosis","volume":"11","author":"Groen","year":"2018","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.jneuroim.2023.578145_bb0050","first-page":"2051","article-title":"miR\u2011660\u20115p is associated with cell migration, invasion, proliferation and apoptosis in renal cell carcinoma","volume":"17","author":"He","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.jneuroim.2023.578145_bb0055","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/jmcb\/mjz015","article-title":"miR-145 improves metabolic inflammatory disease through multiple pathways","volume":"12","author":"He","year":"2020","journal-title":"J. Mol. Cell Biol."},{"key":"10.1016\/j.jneuroim.2023.578145_bb0060","doi-asserted-by":"crossref","first-page":"7637","DOI":"10.1111\/jcmm.15399","article-title":"SNHG16\/miR-605-3p\/TRAF6\/NF-\u03baB feedback loop regulates hepatocellular carcinoma metastasis","volume":"24","author":"Hu","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.jneuroim.2023.578145_bb0065","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jneuroim.2016.04.014","article-title":"MicroRNAs associated with the pathogenesis of multiple sclerosis","volume":"295\u2013296","author":"Huang","year":"2016","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2023.578145_bb0070","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/ene.12624","article-title":"Time course of clinical and neuroradiological effects of delayed-release dimethyl fumarate in multiple sclerosis","volume":"22","author":"Kappos","year":"2015","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2023.578145_bb0075","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/eji.201646716","article-title":"TGF-\u03b2 regulation of encephalitogenic and regulatory T cells in multiple sclerosis","volume":"47","author":"Lee","year":"2017","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jneuroim.2023.578145_bb0080","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1111\/ene.14282","article-title":"MicroRNA-4443 regulates monocyte activation by targeting tumor necrosis factor receptor associated factor 4 in stroke-induced immunosuppression","volume":"27","author":"Li","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2023.578145_bb0085","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.omtn.2021.05.003","article-title":"miR-940 is a new biomarker with tumor diagnostic and prognostic value","volume":"25","author":"Li","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.jneuroim.2023.578145_bb0090","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1177\/1352458520937282","article-title":"Dimethyl fumarate treatment shifts the immune environment toward an anti-inflammatory cell profile while maintaining protective humoral immunity","volume":"27","author":"Longbrake","year":"2021","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2023.578145_bb0095","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/cen3.12131","article-title":"Differentially expressed microRNA in multiple sclerosis: a window into pathogenesis?","volume":"5","author":"Martin","year":"2014","journal-title":"Clin. Exp. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2023.578145_bb0100","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00490","article-title":"Experimental demyelination and axonal loss are reduced in MicroRNA-146a deficient mice","volume":"9","author":"Martin","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2023.578145_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01110","article-title":"Absence of miRNA-146a differentially alters microglia function and proteome","volume":"11","author":"Martin","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2023.578145_bb0110","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/fneur.2018.00005","article-title":"Emerging understanding of the mechanism of action for dimethyl fumarate in the treatment of multiple sclerosis","volume":"9","author":"Mills","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jneuroim.2023.578145_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1590\/1414-431x20209740","article-title":"miR-660-5p promotes breast cancer progression through down-regulating TET2 and activating PI3K\/AKT\/mTOR signaling","volume":"53","author":"Peng","year":"2020","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.jneuroim.2023.578145_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ibneur.2022.11.001","article-title":"MicroRNAs as a possible biomarker in the treatment of multiple sclerosis","author":"P\u00e9rez","year":"2022","journal-title":"IBRO Neurosci. Rep."},{"key":"10.1016\/j.jneuroim.2023.578145_bb0125","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3390\/ijms222111887","article-title":"Circulating miRNAs as potential biomarkers distinguishing relapsing\u2013remitting from secondary progressive multiple sclerosis. A review","volume":"22","author":"Pietrasik","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jneuroim.2023.578145_bb0130","first-page":"159","article-title":"MicroRNA-23a\/24-2\/27a as a potential diagnostic biomarker for cancer: a systematic review and meta-analysis","volume":"8","author":"Quan","year":"2018","journal-title":"Mol. Clin. Oncol."},{"key":"10.1016\/j.jneuroim.2023.578145_bb0135","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01564","article-title":"Immunological aspects of approved MS therapeutics","volume":"10","author":"Rommer","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2023.578145_bb0140","doi-asserted-by":"crossref","first-page":"578","DOI":"10.3389\/fimmu.2014.00578","article-title":"MicroRNA-146a: A dominant, negative regulator of the innate immune response","volume":"5","author":"Saba","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2023.578145_bb0145","doi-asserted-by":"crossref","first-page":"R115","DOI":"10.1530\/VB-20-0012","article-title":"MicroRNA-145 targets in cancer and the cardiovascular system: evidence for common signaling pathways","volume":"2","author":"Sawant","year":"2020","journal-title":"Vasc. Biol."},{"key":"10.1016\/j.jneuroim.2023.578145_bb0150","doi-asserted-by":"crossref","first-page":"4777","DOI":"10.1073\/pnas.1603907113","article-title":"Dimethyl fumarate treatment induces adaptive and innate immune modulation independent of Nrf2","volume":"113","author":"Schulze-Topphoff","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2023.578145_bb0155","first-page":"1324","article-title":"Dimethyl fumarate decreases neurofilament light chain in CSF and blood of treatment na\u00efve relapsing MS patients","volume":"90","author":"Sejbaek","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2023.578145_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-019-6297-6","article-title":"The value of miR-155 as a biomarker for the diagnosis and prognosis of lung cancer: a systematic review with meta-analysis","volume":"19","author":"Shao","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jneuroim.2023.578145_bb0165","doi-asserted-by":"crossref","first-page":"6219","DOI":"10.1007\/s11033-011-1441-7","article-title":"Circulating microRNAs involved in multiple sclerosis","volume":"39","author":"Siege","year":"2012","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.jneuroim.2023.578145_bb0170","first-page":"111","article-title":"miR-320 and inflammation regulation in experimental autoimmune encephalomyelitis through interference with tumor growth factor-\u03b2 signaling pathway","volume":"2","author":"Talebi","year":"2020","journal-title":"Immunoregulation"},{"key":"10.1016\/j.jneuroim.2023.578145_bb0175","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/path.5399","article-title":"MicroRNAs in gray and white matter multiple sclerosis lesions: impact on pathophysiology","volume":"250","author":"Teuber-Hanselmann","year":"2020","journal-title":"J. Pathol."},{"key":"10.1016\/j.jneuroim.2023.578145_bb0180","first-page":"173","article-title":"MicroRNAs as T lymphocyte regulators in multiple sclerosis","volume":"15","author":"Wang","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.jneuroim.2023.578145_bb0185","series-title":"Serum Based miRNA as a Diagnostic Biomarker for Multiple Sclerosis: A Systematic Review and Meta-Analysis","first-page":"947","volume":"51","author":"Zailaie","year":"2021"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572823001315?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572823001315?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T11:37:47Z","timestamp":1736336267000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572823001315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":37,"alternative-id":["S0165572823001315"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2023.578145","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Whole blood miRNAs in relapsing MS patients treated with dimethyl fumarate in the phase 4 TREMEND trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2023.578145","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"578145"}}